EBS Emergent BioSolutions Inc.

NEUTRAL Impact: 2/10 Insider Cluster (3 insiders)
Horizon days Filed Apr 30, 2026 Processed 1mo ago
Insider cluster: 3 insiders, $0.4M total
Latest settled — T+20d ⚠ clustered
EBS ▲ +11.54% at T+20d
NEUTRAL call ✓ call won +11.54% · α vs SPY +6.58% · entry $8.23 → $9.18
Next anchor: T+60d in 6w
Currently $8.32 · +1.09% from $8.23 entry
Entry anchored
Apr 29, 03:59 PM ET
via Databento tick
T+1d
+2.92%
call +2.92% · α +2.70%
$8.47
settled 6w ago
T+5d
+10.57%
call +10.57% · α +8.84%
$9.10
settled 5w ago
T+20d
+11.54%
call +11.54% · α +6.58%
$9.18
settled 16d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Three directors of Emergent BioSolutions sold a total of approximately $385K in open-market shares over two days, representing less than 0.1% of market cap. This is routine insider selling, not indicative of material concerns, especially given concurrent non-cash stock grants to the same directors.

Key Financial Metrics

Direction
selling
Total Value
$385.0K
Insiders
3

Actionable Insight

Insider selling is routine and not actionable. Monitor upcoming earnings for any fundamental changes, but no immediate trading signal from this cluster.

Key Facts

  • 3 directors sold shares: Katkin Keith ($128K), DeGolyer Donald W ($121K), Zoon Kathryn C ($135K)
  • Total open-market sales: ~$385K, ~0.09% of $437M market cap
  • All sales occurred at ~$8.28-$8.36 per share on April 30 and May 1, 2026
  • Multiple directors also received non-cash stock grants (A) on April 30, 2026

Financial Impact

Total insider sales of $385K are trivial relative to $437M market cap

insider ownership

Risk Factors

  • Further insider selling if negative news emerges
  • No C-suite participation reduces signal

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EBS-1777930260656
14 reports for EBS
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +14.89%Apr 29, 2026
Filters
Rows
Reports for EBS — sortable, filterable
Type Now
Jun 4, 2026
9d ago
Press Release
NEUTRAL ★ 2/10
$8.44 $8.07▼ −4.38%▼ −1.79%$8.32 (−1.42%)
Apr 30, 2026
6w ago
Press Release
MIXED ★ 6/10
$8.47 $8.54▲ +0.83%▲ +1.17%$8.32 (−1.77%)
Apr 30, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $8.47▲ +2.92%▲ +2.70%$8.32 (+1.09%)
Apr 29, 2026
6w ago
Press Release
BULLISH ★ 4/10
$7.99 $8.23▲ +3.00%▲ +1.98%$8.32 (+4.13%)
Apr 29, 2026
6w ago
Press Release
NEUTRAL ★ 1/10
$7.99 $8.23▲ +3.00%▲ +1.98%$8.32 (+4.13%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $7.99▼ −2.92%▼ −2.91%$8.32 (+1.09%)
Apr 28, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$8.23 $7.99▼ −2.92%▼ −2.91%$8.32 (+1.09%)
Apr 27, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.12▼ −1.34%▼ −1.33%$8.32 (+1.09%)
Apr 16, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$8.81 $8.35▼ −5.22%▼ −5.03%$8.32 (−5.56%)
Apr 16, 2026
8w ago
Press Release
BEARISH ★ 7/10
$8.81 $8.35▲ +5.22%▲ +5.03%$8.32 (+5.56%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (46h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access